Truist Financial Maintains Merck & Co(MRK.US) With Buy Rating, Announces Target Price $132

储亿银行维持默沙东(MRK.US)买入评级，目标价132美元

moomoo资讯 · 10/09 10:32 · 评级/大行评级

Truist Financial analyst Srikripa Devarakonda maintains $Merck & Co (MRK.US)$ with a buy rating, and sets the target price at $132.

According to TipRanks data, the analyst has a success rate of 54.1% and a total average return of 13.5% over the past year.

AnalystRecentRatingAutoNews_202856_20241008_251ec9d77485961552ca4b126b995df847e727bf_1728484262567228_mm_en

Furthermore, according to the comprehensive report, the opinions of $Merck & Co (MRK.US)$'s main analysts recently are as follows:

Expectations are set slightly above consensus for the upcoming Q3 sales, with particular attention on management's commentary regarding Gardasil and, to a lesser extent, Winrevair. While there's a positive outlook on Winrevair, it's anticipated that the resolution of the Gardasil issue in China may take some time, and it's uncertain whether sufficient clarity will be provided to alleviate investor concerns in this quarter.
The firm anticipates a tough quarter for the large-cap biopharmaceutical sector as part of an earnings preview.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

储亿银行分析师Srikripa Devarakonda维持$默沙东 (MRK.US)$买入评级，目标价132美元。

根据TipRanks数据显示，该分析师近一年总胜率为54.1%，总平均回报率为13.5%。

AnalystRecentRatingAutoNews_202856_20241008_251ec9d77485961552ca4b126b995df847e727bf_1728484262567228_mm_sc

此外，综合报道，$默沙东 (MRK.US)$近期主要分析师观点如下：

对于即将到来的第三季度销售，预期略高于共识水平，特别关注管理层对Gardasil以及在较小程度上Winrevair的评论。虽然对Winrevair持乐观态度，但预计中国Gardasil问题的解决可能需要一些时间，目前还不确定本季度能否提供足够清晰度来缓解投资者的担忧。
公司预计大型生物制药板块将迎来艰难的一个季度，这是财报预览的一部分。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Truist Financial Maintains Merck & Co(MRK.US) With Buy Rating, Announces Target Price $132

Truist Financial Maintains Merck & Co(MRK.US) With Buy Rating, Announces Target Price $132

风险及免责提示

声明